Table 3.

ITT analyses

Characteristics	Total number of UTIs	Risk of UTI (RR, 95% CI)a	Hazard of first UTI (HR, 95% CI)a	Hazard of second UTI (HR, 95% CI)b
Placebo	66	Ref.	Ref.	Ref.
Pravastatin	25	0.43 (0.21–0.88)	0.58 (0.32–1.03)	0.25 (0.08–0.77)
Pravastatin + fosinopril	62	1.04 (0.57–1.89)	1.07 (0.66–1.75)	0.48 (0.22–1.05)
Pravastatin versus no pravastatin
no pravastatin	130	Ref.	Ref.	Ref.
pravastatin	87	0.71 (0.44–1.15)	0.83 (0.57–1.20)	0.48 (0.25–0.89)

Abbreviations: UTI, urinary tract infection; RR, relative risk; CI, confidence interval; HR, hazard ratio; Ref., reference category.

^aAdjusted for gender.

^bAdjusted for urinary albumin excretion.